Nicolò Accanto
The 2026 Nobel Prize in Medicine recognizes a revolution in the field of experimental neuroscience: optogenetics. Karl Deisseroth, Peter Hegemann, and Georg Nagel have forever changed the way we study how the brain works.
Thanks to optogenetics, it is now possible to activate or inhibit specific neuronal populations simply by illuminating them with light at the correct wavelength. Its great advantage lies in its genetic precision, which allows light-sensitive proteins to be expressed only in neurons that share a specific molecular identity. In this way, by illuminating them, we can control their activity while the other neurons continue to function normally.
When applied to laboratory animals, such as mice, while they are performing a specific behavior, neuroscientists can determine what happens when those neurons are inhibited (does the animal stop performing that behavior?) or when they are activated (does the same behavior occur?). This provides valuable insights into how the brain works, as it allows researchers to determine which groups of neurons are necessary or sufficient to produce specific behaviors.